Diffusion Weighted Imaging

PROCEDURE11 trials

Conditions

Acute Myeloid LeukemiaAcute Promyelocytic Leukemia With PML-RARAAdult Brain GlioblastomaAdult Giant Cell GlioblastomaAdult GlioblastomaAdult GliosarcomaBenign Breast NeoplasmBreast Cancer

Early Phase 1

18F-DOPA-PET in Planning Surgery in Patients With Gliomas

CompletedNCT02020720

Mayo ClinicMalignant Glioma, Recurrent Brain Neoplasm

Start: 2014-01-22End: 2024-01-10Updated: 2025-01-23

CompletedNCT06090630

Jonsson Comprehensive Cancer CenterBenign Breast Neoplasm, Breast Carcinoma, Malignant Breast Neoplasm

Start: 2017-07-31End: 2023-02-03Updated: 2024-04-17

Phase 1

Cediranib, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma

CompletedNCT00662506

National Cancer Institute (NCI)Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma

Start: 2008-04-30End: 2014-04-30Updated: 2023-06-06

Pembrolizumab in Treating Younger Patients With Recurrent, Progressive, or Refractory High-Grade Gliomas, Diffuse Intrinsic Pontine Gliomas, Hypermutated Brain Tumors, Ependymoma or Medulloblastoma

Active, not recruitingNCT02359565

National Cancer Institute (NCI)Constitutional Mismatch Repair Deficiency Syndrome, Lynch Syndrome, Malignant Glioma +8

Start: 2015-06-03End: 2027-01-16Updated: 2026-04-03

PET/MRI, 18F-FDG PET/CT and Whole Body MRI in Finding Extramedullary Myeloid Leukemia in Patients With Newly Diagnosed Acute Myeloid Leukemia

Active, not recruitingNCT02390635

M.D. Anderson Cancer CenterAcute Myeloid Leukemia, Acute Promyelocytic Leukemia With PML-RARA

Start: 2020-07-15End: 2027-09-15Updated: 2025-11-03

Phase 2

18F-DOPA-PET in Finding Tumors in Patients With Newly Diagnosed Gliomas Undergoing Radiation Therapy

CompletedNCT01991977

Mayo ClinicMalignant Glioma

Start: 2013-12-31End: 2024-07-15Updated: 2025-10-20

Unknown Phase

MRI Study With Ferumoxytol in Assessing Early Response in Patients With Glioblastoma Multiforme Receiving Temozolomide and Radiation Therapy

CompletedNCT00660543

OHSU Knight Cancer InstituteAdult Brain Glioblastoma

Start: 2006-12-31End: 2014-06-30Updated: 2017-05-16

MRI and PET Imaging in Predicting Treatment Response in Patients With Stage IB-IVA Cervical Cancer

TerminatedNCT01992861

University of WashingtonCervical Adenocarcinoma, Cervical Adenosquamous Carcinoma, Cervical Squamous Cell Carcinoma, Not Otherwise Specified +10

Start: 2014-02-14End: 2022-01-31Updated: 2023-06-26

Correlation Between the Genetic and Neuroimaging Signatures in Newly Diagnosed Glioblastoma Patients Before Surgery

WithdrawnNCT02590497

Ohio State University Comprehensive Cancer CenterGlioblastoma

Start: 2016-03-20End: 2017-10-26Updated: 2018-01-31

An Investigational Scan (Intravoxel Incoherent Motion Diffusion Weighted Imaging) for the Evaluation of Colorectal Cancer Liver Metastases Treatment Response

RecruitingNCT04796818

M.D. Anderson Cancer CenterMetastatic Colorectal Carcinoma, Metastatic Malignant Neoplasm in the Liver, Resectable Colorectal Carcinoma +4

Start: 2020-08-12End: 2026-01-31Target: 70Updated: 2026-01-14

Quantitative MRI Assessment of Breast Cancer Therapy Response

RecruitingNCT05704062

Corewell Health EastBreast Cancer

Start: 2010-03-18End: 2027-05-31Target: 135Updated: 2025-06-11

Radiology Artificial Intelligence2023-11-227 citations

INTERCEPT H3: a multicenter phase I peptide vaccine trial for the treatment of H3-mutated diffuse midline gliomas

Neurological Research and Practice2023-10-198 citations

Radiomics Repeatability Pitfalls in a Scan-Rescan MRI Study of Glioblastoma.

2020-12-1634 citations

Abstract B12: Adding angiotensin-system inhibitors to anti-angiogenic therapy reduces vasogenic edema in newly diagnosed glioblastomas but not in recurrent disease

Cancer Research2017-01-152 citations

Abstract 3975: Matrix-depleting anti-hypertensives decompress tumor blood vessels and improve perfusion in patients with glioblastomas receiving anti-angiogenic therapy

Cancer Research2016-07-158 citations

INCREASED PERFUSION DUE TO VASCULAR NORMALIZATION IMPROVES OXYGENATION AND SURVIVAL IN GLIOBLASTOMA PATIENTS TREATED WITH CEDIRANIB WITH OR WITHOUT CHEMORADIATION

Neuro-Oncology2014-07-011 citations